Remove 2019 Remove Blogging Remove Pricing
article thumbnail

What Does the Post Crash VC Market Look Like?

Both Sides of the Table

<== Our conclusion was that this isn’t a temporary blip that will swiftly trend-back up in a V-shaped recovery of valuations but rather represented a new normal on how the market will price these companies somewhat permanently. We’ll just wait until companies that last raised in 2019 or 2020 come to market.” It’s just math.

article thumbnail

SPECIAL REPORT: 2019 Biopharma Outlook – Facing an Uncertain Future

Xconomy

biopharmaceutical industry is dealing with unprecedented threats on several fronts: public backlash against high drug prices, slowing sales, and the possibility of more government regulation. After years of boom times, the U.S. In this Report, you’ll learn: The key indicators that suggest a possible downturn is on the way.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

SPECIAL REPORT: 2019 Blockchain Outlook — Reality Check

Xconomy

After a breakout year in 2017, the blockchain sector suffered a series of blows in 2018, from crashing cryptocurrency prices to increased regulatory scrutiny of crypto ventures and deepening skepticism about whether the technology was actually useful.

article thumbnail

Bio Roundup: 2019 Trials, Pilgrim Price Chat, Pre-Xmas Sales & More

Xconomy

It’s beginning to look a lot like, well, the last roundup of the year, with plenty of news to pack in before our holiday breather.

article thumbnail

Gossamer Bio Adds $276M in Second Biotech “Unicorn” IPO of 2019

Xconomy

During the partial federal government shutdown in January, Gossamer announced it would pursue a little-used path to the public markets that required it to fix a share price, which was locked in for 20 days. The amount raised surpassed expectations.

article thumbnail

Now approved in LA, Abodu’s backyard homes can now go from contract to completion in as little as 30 days

TechCrunch LA

Abodu began installing homes through a pre-approval process back in 2019, when the city of San Jose created a program that allowed developers of alternative dwelling units to submit plans for pre-approval to cut the time for homeowners. That approval process means that ADU developers like Abodu can be permitted in one hour. Photo via Abodu.

article thumbnail

Two Days, Five Biotech IPOs, and $359M Raised for Clinical Trials

Xconomy

Five biotechs priced their IPOs and at least one more is coming. According to IPO research firm Renaissance Capital , 47 IPOs have priced so far this year across all sectors, down 27 percent compared to the same period in 2018. To date in 2019, 23 healthcare-related companies have gone public, the most of any sector.